How to Optimize Multi-Facility Pharma Delivery: Reducing Empty Miles with Intelligent Routing

A pharmaceutical distributor managing five facilities dispatches 40 vehicles every single day. Yet when the numbers are crunched at the end of the month, nearly 30% of those miles were driven empty — no product, no value, no purpose. That’s not just fuel going up in smoke. Empty miles in pharma distribution mean delayed critical medications, strained carrier relationships, ballooning operational costs, and in a heavily regulated industry, a very real compliance risk.

Now multiply that across six facilities. Ten. A national network.

The problem doesn’t shrink with scale — it compounds.

Multi-facility pharma delivery optimization is no longer a logistics luxury. It’s a business imperative. With rising fuel costs, tightening DSCSA regulations, and patient outcomes directly tied to on-time delivery, pharmaceutical distributors can no longer afford to leave routing decisions to spreadsheets, siloed dispatch teams, or gut instinct.

The good news? Intelligent routing technology is changing the game — and the results are measurable.

In this blog, we’ll break down:

• Why multi-facility pharma operations are uniquely prone to empty miles
• How AI-powered intelligent routing eliminates those inefficiencies
• What role a purpose-built Last Mile TMS plays in coordinating deliveries across facilities
• And how leading pharma distributors are cutting costs, improving compliance, and delivering more — with fewer wasted miles

Whether you manage two distribution centers or twenty, this guide will show you exactly where the inefficiency hides — and how to fix it.

What Are Empty Miles in Pharmaceutical Distribution?

Empty miles — also called “deadhead miles” — refer to the distance a delivery vehicle travels without any cargo on board. In pharmaceutical distribution, this happens when vehicles return from a delivery without a backhaul load, reposition between facilities unloaded, or depart a hub before being fully utilized. Every mile driven empty is a mile that generates cost with zero revenue return.

Why Pharma Is More Vulnerable Than Other Industries

Most industries tolerate a degree of empty miles as an unavoidable cost of doing business. Pharmaceutical distribution doesn’t have that luxury — and here’s why the problem runs deeper:

Strict Delivery Windows Medications, vaccines, and temperature-sensitive biologics must arrive within precise time windows. This urgency often forces dispatchers to send out partially loaded or unloaded vehicles rather than wait for a consolidated load — driving up empty miles by default.

Complex Multi-Stop, Multi-Facility Networks Unlike retail or e-commerce, pharma distributors often operate across multiple distribution centers, regional hubs, and transfer points simultaneously. Without a unified view of the entire network, vehicles are dispatched in silos — with no visibility into whether a nearby facility could have consolidated that load.

Temperature & Compliance Constraints Cold chain products cannot simply be rerouted or consolidated freely. Temperature zones, handling protocols, and DSCSA chain-of-custody requirements limit how flexibly loads can be combined — making intelligent, constraint-aware routing essential, not optional.

High-Frequency, Small-Volume Deliveries Pharma last-mile delivery often involves frequent, small-batch shipments to hospitals, clinics, and pharmacies — leaving significant unused vehicle capacity on every trip and increasing the likelihood of empty return journeys.

The Real Cost of Empty Miles in Pharma

The financial impact is significant and often underestimated. Industry data suggests that empty miles can account for 15% to 35% of total fleet operating costs in complex distribution networks. For a mid-sized pharma distributor running a fleet of 40+ vehicles across multiple facilities, that translates to hundreds of thousands of dollars in avoidable expense — annually.

But the cost isn’t only financial:

• Operational cost — Fuel, driver hours, and vehicle wear with zero revenue offset
• Capacity waste — Vehicles that could carry product are moving air instead
• Compliance risk — Rushed, unplanned dispatch decisions increase the chance of documentation gaps and regulatory exposure
• Patient impact — Delayed deliveries caused by inefficient routing can directly affect patient care timelines

In an industry where a missed delivery isn’t just a bad review — it’s a safety concern — empty miles are a problem that demands a systemic solution.

Why Multi-Facility Pharma Operations Are Prone to Inefficiency

Managing pharmaceutical delivery across multiple facilities isn’t just logistically complex — it’s a system designed, almost by default, to generate inefficiency. When distribution centers operate independently, each making its own routing decisions without a unified view of the broader network, the cracks appear fast: duplicated trips, underutilized vehicles, compliance gaps, and avoidable delays.

The core challenges driving this inefficiency aren’t random. They’re structural — and they show up consistently across pharma networks of every size.

5 Key Challenges Unique to Multi-Facility Pharma Networks

At a glance, the biggest inefficiency drivers are:

• Fragmented dispatch across locations — each facility routing independently with no network-wide coordination
• Siloed visibility between hubs — no shared real-time view of inventory, vehicles, or delivery status
• Manual routing decisions — spreadsheet-driven planning that can’t adapt to real-world disruptions
• Compliance pressure (DSCSA & GDP) — regulatory requirements that add complexity to every routing decision
• Temperature-sensitive load constraints — cold chain rules that restrict how and when loads can be consolidated

1. Fragmented Dispatch Across Locations

In a multi-facility pharma network, each distribution center typically operates its own dispatch team, its own routing logic, and its own carrier relationships. What looks like operational independence is actually a recipe for duplication.

Two facilities 30 miles apart might both dispatch vehicles to the same hospital on the same morning — completely unaware of each other. There’s no mechanism to consolidate, coordinate, or even communicate in real time. The result? Double the trips, double the empty miles, and double the cost — for a single delivery destination.

2. Siloed Visibility Between Hubs

Visibility in multi-facility operations is often fragmented by design. Each hub sees its own orders, its own fleet, and its own exceptions — but has no window into what’s happening across the broader network.

This lack of a unified view creates a dangerous blind spot. Shipment delays at one hub cascade into missed windows at the next. Transfer pallets sit untracked at cross-dock points. Carriers complete deliveries with no record passing back to the originating facility. Without end-to-end visibility, every decision is made on incomplete information — and incomplete information leads to inefficient routing, every time.

3. Manual Routing Decisions

Many pharma distributors still rely on route planners who manually assign stops, estimate drive times, and sequence deliveries based on experience rather than data. While experienced planners bring real value, manual routing simply cannot process the volume of variables that modern multi-facility pharma delivery demands:

• Real-time traffic shifts
• Last-minute order additions or cancellations
• Driver availability changes
• Vehicle capacity fluctuations
• Regulatory documentation requirements per stop

The moment one variable changes mid-route, a manually built plan becomes outdated — and there’s no automatic mechanism to reoptimize. Dispatchers are left firefighting instead of planning.

4. Compliance Pressure — DSCSA & GDP

Pharmaceutical distribution operates under some of the most rigorous regulatory frameworks in any industry. The Drug Supply Chain Security Act (DSCSA) requires end-to-end traceability of every prescription drug unit — from manufacturer to patient. Good Distribution Practice (GDP) mandates strict controls over storage, handling, and transportation conditions at every point in the chain.

In a multi-facility environment, meeting these requirements becomes exponentially harder. Every hub transition, every carrier handoff, and every route change must be documented with precision. When routing decisions are made manually or in silos, compliance documentation lags behind operations — creating audit risk, regulatory exposure, and potential product recalls.

5. Temperature-Sensitive Load Constraints

Unlike general freight, a significant portion of pharmaceutical products — biologics, vaccines, insulin, oncology medications — require strict temperature-controlled environments throughout transit. This creates a routing constraint that most standard logistics systems simply aren’t built to handle.

You cannot freely consolidate a cold chain shipment with ambient cargo. You cannot reroute a temperature-sensitive load through an unqualified hub. You cannot extend a delivery window without monitoring and documenting temperature exposure throughout.

These constraints dramatically limit routing flexibility — and without an intelligent system that understands and respects these rules automatically, planners are forced to make conservative, often inefficient routing decisions just to stay safe.

The Compounding Effect

Here’s what makes multi-facility pharma inefficiency so costly: none of these challenges exist in isolation. Fragmented dispatch feeds siloed visibility. Siloed visibility forces manual decisions. Manual decisions struggle under compliance pressure. Compliance pressure restricts temperature-sensitive routing. Each challenge amplifies the next — creating a compounding inefficiency loop that grows more expensive and more risky as the network scales.

The answer isn’t more planners, more spreadsheets, or more carrier contracts. It’s a smarter system — one built specifically for the complexity of multi-facility pharmaceutical distribution.

What Is Intelligent Routing and How Does It Work in Pharma?

Intelligent routing is an AI-powered process that automatically calculates, assigns, and continuously optimizes delivery routes across a distribution network — factoring in real-time conditions, operational constraints, and regulatory requirements simultaneously. Unlike traditional routing, it doesn’t just find the shortest path. It finds the smartest path — one that balances speed, cost, compliance, and capacity in a single, automated decision.

How Intelligent Routing Works — In Simple Terms

Intelligent routing in pharma works by continuously ingesting live data — traffic, load constraints, delivery windows, driver availability, and order priority — and using AI to calculate the most efficient, compliant route across every facility in the network. It reoptimizes automatically as conditions change, without human intervention.

That’s the core of it. No spreadsheets. No guesswork. No reactive firefighting. Just a system that sees the entire network at once and makes smarter routing decisions — faster than any human planner can.

Intelligent Routing vs. Static & Manual Routing — What’s the Difference?

Most pharma distributors today still rely on one of two approaches: static routing (pre-set, fixed routes that repeat regardless of real-world conditions) or manual routing (a planner builds routes daily based on experience and available data). Both approaches share the same fundamental flaw — they’re built on yesterday’s information, not today’s reality.

Here’s how intelligent routing changes that:

	Static / Manual Routing	Intelligent Routing
Route Planning	Fixed or manually built	Dynamically generated & reoptimized
Real-Time Adaptability	None or very limited	Continuous, automatic adjustment
Multi-Facility Coordination	Siloed per facility	Unified across all hubs & DCs
Compliance Handling	Manual documentation	Automated, embedded in every route
Cold Chain Awareness	Manually enforced	System-enforced constraints
Response to Disruptions	Reactive (dispatcher intervenes)	Proactive (system reoptimizes instantly)
Capacity Utilization	Often underutilized	Maximized through load consolidation

The gap isn’t just operational — it’s strategic. Static and manual routing keep your network running. Intelligent routing keeps it optimized.

5 Key Inputs That Power Intelligent Routing in Pharma

What makes intelligent routing truly powerful is the breadth and depth of data it processes — simultaneously, in real time. Here’s what the system ingests and acts on:

1. Real-Time Traffic Conditions

Intelligent routing continuously monitors live traffic data — accidents, congestion, road closures, weather delays — and dynamically adjusts routes mid-execution. If a driver is 20 minutes from a delivery and a traffic incident adds 40 minutes to their ETA, the system doesn’t wait for a dispatcher to notice. It reroutes automatically, recalculates downstream stop times, and flags any affected delivery windows — all without human intervention.

2. Load Weight & Temperature Constraints

In pharma distribution, not every load can go on every vehicle — and not every route can accommodate every product type. Intelligent routing enforces these constraints automatically:

• Cold chain products are only assigned to temperature-qualified vehicles
• Load weight is balanced across the fleet to maximize capacity without exceeding limits
• Mixed-temperature shipments are flagged, separated, or consolidated according to predefined handling rules

This eliminates the manual guesswork that often leads to compliance violations or product integrity failures.

3. Delivery Time Windows

Hospitals, clinics, and pharmacies operate on strict receiving schedules. A delivery that misses its window doesn’t just inconvenience the recipient — it can trigger a compliance event, delay patient care, or require a costly re-delivery attempt.

Intelligent routing maps every stop against its required delivery window and sequences the route to honor every commitment — across every vehicle, every facility, and every carrier in the network. When a window is at risk, the system alerts dispatchers proactively, not after the fact.

4. Driver Availability & Hours of Service

Routing decisions can’t be made in isolation from the people executing them. Intelligent routing factors in:

• Driver shift start and end times
• Hours of service (HOS) compliance limits
• Real-time driver location and current workload
• Skill or certification requirements for specific product types

This ensures that routes are not only optimized for efficiency — but actually executable by the right driver, at the right time, without pushing regulatory HOS boundaries.

5. Multi-Stop Sequencing Across Facilities

This is where intelligent routing delivers its most significant pharma-specific advantage. Rather than optimizing routes facility-by-facility in isolation, an intelligent TMS sequences stops across the entire network — factoring in:

• Cross-facility load consolidation opportunities
• Trunk & relay routing between hubs
• Backhaul availability on return legs
• Inter-facility transfer timing and handoff coordination

The result is a network-wide routing plan that eliminates duplicated trips, fills empty return miles, and ensures every vehicle is working at maximum productive capacity — from first dispatch to final delivery.

Why This Matters Specifically for Pharma

Every industry benefits from smarter routing. But pharmaceutical distribution has a unique combination of constraints — regulatory, temperature, time-critical, and patient-safety-driven — that makes intelligent routing not just beneficial, but essential.

A generic routing tool can find a faster path. A pharma-intelligent routing engine finds the fastest compliant, cold-chain-safe, capacity-optimized path — and adjusts it in real time when the world doesn’t go according to plan.

That’s the difference between a routing tool and an intelligent routing system built for pharma.

Retailers are cutting delivery costs without sacrificing customer experience — here’s how they do it. Learn the Strategies

5 Ways Intelligent Routing Reduces Empty Miles Across Multiple Facilities

Empty miles don’t happen by accident — they happen by design. Specifically, they’re the byproduct of routing systems that weren’t built to see the full picture. When dispatch decisions are made facility-by-facility, without a unified network view, inefficiency is inevitable.

Intelligent routing fixes this at the source. Here are the five most impactful ways it eliminates empty miles across multi-facility pharma networks — and how nuVizz makes each one possible.

1. Consolidated Load Planning Across Hubs — Eliminating Duplicate Trips Before They Happen

The Problem: Two distribution centers, 25 miles apart, both schedule morning deliveries to the same hospital cluster. Neither knows the other is going. Two vehicles depart. Two sets of empty return miles follow. This scenario plays out dozens of times a day across uncoordinated pharma networks.

The Intelligent Routing Fix: Consolidated load planning gives dispatchers — and the system itself — a single, unified view of all outbound orders across every facility simultaneously. Before a single vehicle is dispatched, the system identifies:

• Overlapping delivery destinations across hubs
• Opportunities to combine loads from multiple facilities onto a single vehicle
• Which facility is best positioned to own a shared route based on proximity, capacity, and timing

The result is fewer vehicles on the road, higher load utilization per trip, and a dramatic reduction in duplicate mileage before the day even begins.

How nuVizz Does It: nuVizz TMS enables seamless load planning across multiple distribution centers — allowing a single dispatcher to plan, consolidate, and assign loads from multiple facilities in one unified interface. No phone calls between hubs. No duplicated efforts. Just one optimized plan for the entire network.

2. Dynamic Route Reoptimization — Real-Time Adjustments That Keep Every Mile Productive

The Problem: A route planned at 6 AM looks very different by 9 AM. A driver runs late. An urgent STAT order comes in. A road closure adds 45 minutes to a key stop. In a manually managed operation, these disruptions cascade — and dispatchers scramble to patch together a new plan while vehicles continue down an outdated route, burning empty miles along the way.

The Intelligent Routing Fix: Dynamic reoptimization means the routing engine never stops working. As real-world conditions change throughout the day, the system continuously recalculates the most efficient route for every active vehicle — automatically, without waiting for a dispatcher to intervene. New stops are inserted intelligently. Affected time windows are recalculated. Drivers receive updated instructions in real time.

This isn’t reactive problem-solving. It’s proactive route intelligence — keeping every mile purposeful, even when the plan changes.

How nuVizz Does It: nuVizz’s AI-powered route optimization engine dynamically adjusts deliveries based on real-time demand, traffic conditions, and shipment constraints throughout the execution day. When disruptions hit, nuVizz doesn’t just flag the problem — it solves it, automatically reconfiguring routes to protect delivery windows and minimize wasted mileage across the entire fleet.

3. Trunk & Relay Routing — Smarter Hub-to-Hub Movement Across Your Network

The Problem: In multi-facility pharma networks, products frequently need to move between distribution centers, regional hubs, and cross-dock points before reaching their final destination. Without a coordinated routing strategy, these inter-facility movements are often planned independently — generating unloaded legs, misaligned handoffs, and unnecessary repositioning miles between hubs.

The Intelligent Routing Fix: Trunk and relay routing is a network-level strategy that coordinates the movement of product between facilities as part of a single, optimized plan — not as disconnected trips. A “trunk” vehicle handles the high-volume inter-facility leg, while “relay” drivers take over for final-mile delivery at the regional level. Every handoff is timed, planned, and tracked — eliminating the uncoordinated hub-to-hub movements that generate empty miles.

This approach also unlocks significant capacity benefits: trunk vehicles operate at near-full load utilization, while relay drivers handle denser, shorter final-mile routes — maximizing productivity at every stage.

How nuVizz Does It: nuVizz TMS is purpose-built for trunk and relay routing — enabling optimized movement between hubs with full visibility at every transfer point. From the moment a load departs a distribution center to the moment it’s handed off for final-mile delivery, nuVizz tracks every leg, coordinates every handoff, and ensures no vehicle is moving without purpose.

4. Backhaul Optimization — Turning Return Trips Into Revenue-Generating Miles

The Problem: A delivery vehicle completes its final drop and heads back to the distribution center — empty. In pharma distribution, this is an almost universal outcome when return legs aren’t planned as part of the original route. Those empty return miles represent the purest form of avoidable cost: the vehicle is already on the road, the driver is already on shift, and the fuel is already being burned — with nothing to show for it.

The Intelligent Routing Fix: Backhaul optimization treats the return journey as a routing opportunity, not an afterthought. The system identifies:

• Product pickups, returns, or recalls that can be collected on the return leg
• Inbound shipments from suppliers or manufacturers that align with a vehicle’s return path
• Cross-network transfer opportunities where a returning vehicle can carry product destined for another facility

By filling return trips with productive cargo, backhaul optimization converts what was previously a cost-only mile into a value-generating one — directly reducing the effective cost per delivery across the network.

How nuVizz Does It: nuVizz’s multi-tenant last-mile delivery model is designed to maximize vehicle utilization across the full journey — outbound and return. By leveraging network-wide visibility, nuVizz identifies backhaul opportunities in real time, ensuring that return legs contribute to network efficiency rather than simply draining fuel budgets.

5. Predictive Demand Matching — Aligning Vehicle Capacity With Order Volume Before Dispatch

The Problem: Dispatching a 20-foot vehicle for a delivery that fills 40% of its capacity isn’t just wasteful — it’s a missed opportunity to consolidate. When demand forecasting is absent or inaccurate, fleet capacity is routinely misaligned with actual order volume. The result is a fleet that’s simultaneously overstretched in some areas and underutilized in others — generating empty miles in both directions.

The Intelligent Routing Fix: Predictive demand matching uses historical delivery data, order patterns, and AI-driven forecasting to anticipate volume fluctuations before they occur — and align the right vehicle capacity to the right routes in advance. This means:

• Right-sizing vehicle selection based on projected load volume per route
• Pre-positioning fleet capacity at facilities with anticipated high-volume days
• Identifying low-demand periods where consolidation opportunities exist across facilities
• Reducing the frequency of partially loaded dispatches that contribute to empty mileage

The outcome is a fleet that’s consistently deployed at or near optimal capacity — eliminating the chronic underutilization that drives empty miles across multi-facility networks.

How nuVizz Does It: nuVizz leverages AI and ML capabilities to align delivery planning with real-time and forecasted demand — giving pharma distributors the intelligence to deploy the right vehicle, to the right location, at the right time. Combined with nuVizz’s network-wide visibility, predictive demand matching ensures that capacity decisions are driven by data, not assumptions.

The Cumulative Impact

Each of these five strategies delivers measurable value independently. But their real power emerges when they work together — as part of a single, unified intelligent routing platform.

Strategy	Primary Benefit
Consolidated Load Planning	Eliminates duplicate trips before dispatch
Dynamic Reoptimization	Keeps every active mile productive
Trunk & Relay Routing	Coordinates inter-facility movement efficiently
Backhaul Optimization	Converts return legs into productive miles
Predictive Demand Matching	Aligns capacity with volume before it’s needed

Together, these capabilities don’t just reduce empty miles — they systematically remove the conditions that create them. That’s the difference between managing a pharma fleet and truly optimizing one.

The Role of a Last Mile TMS in Multi-Facility Coordination

Intelligent routing is only as powerful as the platform that powers it. And in a multi-facility pharma network, the platform that ties everything together — dispatch, visibility, compliance, and carrier management — is the Last Mile Transportation Management System (TMS).

Without a purpose-built TMS, even the best routing logic breaks down at the edges: a carrier that doesn’t report back in real time, a hub that can’t see what the next hub is doing, a proof of delivery that arrives hours after the fact. A Last Mile TMS eliminates these gaps — not by adding more people to the process, but by building intelligence, visibility, and coordination directly into the system itself.

Here’s what that looks like in practice across a multi-facility pharma operation.

Unifying Dispatch Across All Facilities Into One View

The most immediate and impactful thing a Last Mile TMS does for a multi-facility operation is simple — but transformative: it replaces many disconnected dispatch consoles with one.

In a traditional multi-facility setup, each distribution center has its own dispatch team, its own planning tools, and its own view of the world. Coordination between facilities happens over phone calls, emails, and manual check-ins — slow, error-prone, and completely invisible to anyone outside the loop.

A Last Mile TMS changes the operating model entirely. Every facility, every fleet, every active order, and every in-transit shipment is visible on a single, unified dashboard — in real time. Dispatchers no longer need to call a neighboring hub to find out if a load has departed. Operations managers no longer piece together network status from five different reports. The entire multi-facility operation becomes one coherent, manageable picture — updated continuously, accessible by everyone who needs it.

The operational benefits are immediate:

• Eliminated duplication — overlapping routes and duplicate dispatches are identified and resolved before vehicles leave the dock
• Faster decision-making — dispatchers act on live data, not delayed reports
• Proactive exception management — delays, missed windows, and route deviations are flagged the moment they occur, not discovered hours later
• Network-wide accountability — every facility is held to the same operational standards, with full visibility into performance across the board

Real-Time Visibility Across All Fleet Types — Owned & 3PL

Multi-facility pharma distributors rarely operate with a single, homogeneous fleet. The reality is a mix of owned vehicles, contracted carriers, and third-party logistics (3PL) providers — each with their own tracking systems, reporting cadences, and operational workflows. Managing this fragmented carrier ecosystem is one of the most persistent visibility challenges in pharma distribution.

A purpose-built Last Mile TMS solves this by creating a single visibility layer across every fleet type — regardless of who owns the vehicle or how the carrier operates.

• Owned fleet vehicles are tracked in real time via integrated GPS and driver mobile apps
• 3PL carriers are onboarded into the platform — either through a dedicated carrier app or API integration — and held to the same visibility and documentation standards as owned fleet
• Contract drivers receive route assignments, delivery instructions, and compliance requirements through the same system interface as full-time drivers

The result is a unified, real-time view of every vehicle in the network — owned or outsourced — with no visibility gaps between carrier types. For pharma distributors, this is critical: chain of custody doesn’t pause because a 3PL picked up the load.

How nuVizz Enables Single-User Dispatch Across Multiple DCs

One of nuVizz’s most operationally significant capabilities is its ability to enable a single dispatcher to plan, manage, and execute deliveries across multiple distribution centers simultaneously — from one interface, without switching systems or making cross-facility calls.

This isn’t a minor efficiency gain. For a pharma distributor operating five or ten facilities, replacing five or ten siloed dispatch operations with a single coordinated function means:

• Lower operational overhead — fewer dispatchers needed to manage the same network volume
• Faster load assignment — orders from multiple DCs are consolidated, sequenced, and assigned in a fraction of the time
• Consistent process execution — every facility follows the same SOPs, the same documentation standards, and the same delivery protocols — enforced by the platform, not by individual managers
• Instant cross-facility reallocation — when capacity is tight at one DC, a single dispatcher can immediately identify available capacity at a neighboring facility and reroute accordingly

This single-user, multi-DC capability is what transforms nuVizz from a routing tool into a true network orchestration platform — one that makes multi-facility pharma distribution manageable at scale.

Chain of Custody, ePOD & Carrier Orchestration — The Compliance Backbone

In pharmaceutical distribution, coordination isn’t just an operational priority — it’s a regulatory one. Every product movement, every carrier handoff, and every final delivery must be documented with precision. A Last Mile TMS doesn’t just manage the logistics of multi-facility delivery — it maintains the compliance integrity of every mile in between.

Chain of Custody nuVizz maintains a real-time, unbroken chain of custody across the entire delivery lifecycle — from the moment a product leaves a distribution center to the moment it’s confirmed received at its destination. Every hub transition, carrier handoff, and route change is logged automatically, creating an audit-ready record that satisfies DSCSA traceability requirements without manual documentation effort.

Electronic Proof of Delivery (ePOD) Paper-based proof of delivery is a compliance liability in modern pharma distribution. nuVizz replaces it with digital ePOD — captured at the point of delivery via driver mobile app, including:

• Digital signature capture
• Timestamped delivery confirmation
• Photo documentation where required
• Real-time sync back to the central platform

ePOD data is available instantly — not hours later — giving operations teams, compliance officers, and finance teams immediate access to verified delivery records. Disputes are resolved faster. Invoices are generated on confirmed data. And audit preparation becomes a report pull, not a document hunt.

Carrier Orchestration Managing multiple carriers across multiple facilities without a unified orchestration layer is one of the primary sources of pharma distribution inefficiency. nuVizz’s carrier orchestration capability standardizes how every carrier — owned, contracted, or 3PL — operates within the network:

• Carriers receive standardized job assignments, route instructions, and delivery SOPs through the nuVizz platform
• Performance is tracked against consistent KPIs across all carrier types
• Exceptions are flagged, escalated, and resolved through a single workflow — regardless of which carrier triggered them
• Billing and settlement are automated based on verified ePOD data — eliminating invoice disputes and reconciliation delays

The practical outcome is a carrier ecosystem that behaves like a single, coordinated fleet — even when it’s made up of dozens of independent operators spread across a national distribution network.

Bringing It All Together

A Last Mile TMS is the connective tissue of a high-performing multi-facility pharma operation. It’s what turns five disconnected facilities into one coordinated network. It’s what makes a 3PL carrier as visible and accountable as an owned vehicle. It’s what ensures that every delivery — regardless of origin, carrier, or destination — is planned intelligently, executed compliantly, and documented completely.

In multi-facility pharma distribution, the question is no longer whether you need a Last Mile TMS. The question is whether the one you’re using was built for the complexity you’re managing.

Compliance & Cold Chain — The Non-Negotiables in Pharma Routing

In most industries, route optimization is purely an efficiency conversation — faster deliveries, lower fuel costs, better capacity utilization. In pharmaceutical distribution, it’s something fundamentally different. Every routing decision carries regulatory weight. Every mile driven has a compliance implication. And every delivery, if not properly documented, can become a liability.

This is what separates pharma logistics from every other sector: efficiency and compliance are not competing priorities — they must be achieved simultaneously, on every single shipment.

Route optimization that ignores regulatory requirements isn’t optimization. It’s risk. And in an industry where a compliance failure can mean product recalls, regulatory penalties, or — most critically — compromised patient safety, that risk is simply not acceptable.

Why Route Optimization Cannot Ignore Regulatory Requirements

The instinct in logistics is to optimize for speed and cost. Shortest path. Fewest stops. Lowest fuel burn. In pharma, these objectives are still valid — but they operate within a compliance envelope that cannot be breached, no matter how efficient the route appears on paper.

Consider what a routing decision actually triggers in pharma distribution:

• A route change mid-delivery may require updated chain-of-custody documentation
• A carrier substitution may need to be logged against DSCSA serialization records
• An extended delivery window may require continuous temperature monitoring and exception reporting
• A hub handoff may require GDP-compliant transfer documentation before the product can move

None of these are optional. None of them can be handled manually at scale across a multi-facility network without introducing error, delay, and audit risk. Intelligent routing in pharma must therefore be compliance-aware by design — not compliance-patched after the fact.

DSCSA, GDP & HIPAA — How Intelligent Routing Supports Each

Drug Supply Chain Security Act (DSCSA)

The DSCSA mandates end-to-end traceability of every prescription drug unit moving through the U.S. supply chain — from manufacturer to dispenser. For pharma distributors, this means every product movement must be tracked, every transaction documented, and every handoff recorded with verifiable accuracy.

Intelligent routing supports DSCSA compliance by:

• Automatically capturing and logging every product movement at each network touchpoint
• Maintaining a continuous, unbroken digital chain of custody from origin facility to final delivery
• Flagging any route deviation or carrier substitution that requires updated transaction documentation
• Generating DSCSA-compliant transfer records at every hub handoff — without manual data entry

The practical impact is significant: instead of compliance teams scrambling to reconstruct chain-of-custody records after the fact, every required document is generated automatically — in real time, as the delivery unfolds.

Good Distribution Practice (GDP)

GDP guidelines govern how pharmaceutical products must be stored, handled, and transported throughout the distribution process. They apply not just to warehouses — but to every vehicle, every carrier, and every transit condition along the delivery route.

For intelligent routing, GDP compliance means the system must:

• Assign only GDP-qualified carriers and vehicles to regulated product shipments
• Enforce temperature zone requirements at the route planning stage — before dispatch
• Monitor and document environmental conditions throughout transit
• Ensure that route changes don’t inadvertently expose product to non-compliant handling conditions
• Maintain complete transfer documentation at every point where product changes hands

GDP compliance cannot be retrofitted onto a generic routing decision. It must be embedded into the routing logic itself — so that every route generated is, by default, a GDP-compliant one.

HIPAA — Protecting Patient Data Across the Delivery Network

While HIPAA is primarily associated with healthcare data privacy, its implications extend into pharmaceutical distribution — particularly when deliveries involve patient-specific medications, specialty drugs, or home delivery of prescription products.

Intelligent routing platforms handling pharma last-mile delivery must ensure:

• Patient delivery information is encrypted and access-controlled throughout the dispatch and routing process
• Driver-facing delivery instructions contain only the minimum necessary patient data
• Proof of delivery records containing patient identifiers are stored and transmitted securely
• Carrier and 3PL partners operating within the network meet HIPAA data handling standards

nuVizz addresses this directly — maintaining compliance with HIPAA data security requirements across its entire platform, ensuring that patient privacy is protected at every point in the delivery workflow.

Temperature Monitoring & Exception Alerts — Protecting Product Integrity in Transit

Cold chain integrity is the single most operationally complex compliance requirement in pharmaceutical distribution. A vaccine that warms beyond its required range. A biologic that sits on a loading dock too long. An insulin shipment routed through an unqualified transfer hub. Each of these scenarios doesn’t just create a compliance problem — it potentially renders the product unusable, triggering waste, recalls, and patient safety risks.

Intelligent routing addresses cold chain compliance at three critical stages:

At Planning:

• Temperature-sensitive products are automatically matched to cold-chain-qualified vehicles
• Routes are designed to minimize transit time for high-sensitivity products
• Loading dock dwell times are factored into route sequencing to prevent prolonged ambient exposure

During Transit:

• IoT-integrated temperature sensors provide continuous, real-time monitoring of cargo conditions throughout the delivery journey
• Geofenced alerts notify dispatchers the moment a vehicle enters a zone where temperature risk increases
• If a refrigeration unit malfunctions or a temperature threshold is breached, the system triggers an immediate exception alert — enabling rapid intervention before product integrity is compromised

At Delivery:

• Temperature logs are captured and recorded at the point of delivery alongside ePOD confirmation
• Any temperature excursion during transit is documented, time-stamped, and attached to the delivery record automatically
• Recipients are notified of any temperature events that occurred in transit — ensuring informed acceptance or rejection decisions

This end-to-end cold chain monitoring transforms temperature compliance from a reactive concern into a proactive, system-managed safeguard — one that protects product integrity, reduces waste, and eliminates the documentation gaps that create audit exposure.

Audit-Ready Documentation — Compliance That’s Always Current

In pharmaceutical distribution, an audit can arrive with little warning. Regulatory bodies, customers, and internal compliance teams may request delivery records, chain-of-custody documentation, temperature logs, or carrier performance data at any time. The ability to produce complete, accurate, and instantly retrievable records is not just a best practice — it’s a regulatory necessity.

A purpose-built Last Mile TMS like nuVizz generates audit-ready documentation automatically — as a byproduct of normal operations, not as a separate compliance task:

Document Type	How nuVizz Captures It
Chain of Custody Records	Auto-generated at every product touchpoint and hub handoff
DSCSA Transaction Documentation	Captured in real time at dispatch, transfer, and delivery
Temperature Logs	Continuous IoT sensor data, time-stamped and delivery-linked
Electronic Proof of Delivery	Digital signature, photo, timestamp — synced instantly
Carrier Performance Records	On-time rates, exception history, GDP qualification status
Route Deviation Logs	Every unplanned route change flagged, recorded, and explained

When an audit request arrives, nuVizz users don’t spend days reconstructing records from disconnected systems. Every required document is already complete, already accurate, and retrievable in seconds — giving compliance teams confidence and regulators exactly what they need.

Compliance Is Not a Feature — It’s a Foundation

The most important shift in thinking for pharma distributors evaluating intelligent routing is this: compliance is not a module you add to a routing platform. It’s a foundation the platform must be built on.

A generic TMS optimized for speed and cost can be configured to capture some compliance data. But a purpose-built pharma routing platform embeds regulatory requirements — DSCSA, GDP, HIPAA, cold chain — directly into every routing decision, every carrier assignment, and every delivery workflow. The difference isn’t a checkbox. It’s the difference between compliance as an afterthought and compliance as an operating standard.

In pharmaceutical distribution, the only route worth taking is one that’s efficient, compliant, and completely documented — from origin to delivery, without exception.

Real-World Results — What Optimized Pharma Routing Looks Like

Strategy and technology only matter if they deliver measurable outcomes in the real world. Intelligent routing, unified dispatch, cold chain compliance, and carrier orchestration are compelling concepts — but for pharma distribution leaders evaluating a Last Mile TMS, the question that matters most is simple:

What actually changes when you implement this?

The answer, based on outcomes across nuVizz’s pharma and healthcare client base, is: quite a lot. Here’s what optimized multi-facility pharma routing looks like when it moves from theory to practice.

The Metrics That Matter — Before & After Intelligent Routing

The impact of intelligent routing in pharma distribution isn’t felt in one area — it ripples across the entire operation. From fleet efficiency to compliance posture to customer satisfaction, the numbers tell a consistent story:

KPI	Typical Before	After nuVizz Deployment
Empty Mile Rate	25% – 35% of total fleet miles	Reduced by up to 30%
On-Time Delivery Rate	85% – 90%	98%+ across the network
Delivery Accuracy	95% – 97%	100% target achieved
Vehicle Utilization	55% – 65% average capacity	80%+ average capacity
Dispatch Time Per Route	45 – 90 minutes manually	Under 10 minutes with automation
Dwell Time at Hubs	Untracked or manually logged	Reduced & continuously monitored
Billing Cycle Time	5 – 10 days post-delivery	Same-day, ePOD-triggered
Compliance Documentation	Reconstructed post-delivery	Real-time, auto-generated

These aren’t incremental improvements. They represent a fundamental shift in how a pharma distribution network operates — and what it costs to run one.

From Fragmented Fleet to Fully Coordinated Network

One of the most consistent challenges nuVizz encounters when onboarding large pharma distributors is the fragmented fleet problem — a network of five, ten, or twenty carriers, each operating independently, each with its own tracking system, each delivering inconsistent visibility back to the distributor.

One of the world’s largest pharmaceutical distributors faced exactly this challenge: managing a massive network of third-party carriers across multiple regions, with no standardized execution framework and limited real-time visibility into what any of them were doing at any given moment.

After deploying nuVizz, the outcomes were transformative:

• Standardized business processes were enforced across the entire carrier ecosystem — without requiring boots on the ground at every carrier location
• Every 3PL driver — regardless of employer — operated through the nuVizz platform, capturing the same DSCSA-compliant data and providing the same level of delivery visibility
• Chain of custody became continuous and unbroken across the entire network — not just within owned fleet operations
• Customer-facing visibility improved dramatically — real-time ETAs and delivery confirmations replaced the manual status calls that had previously consumed hours of operations team time daily

The result wasn’t just a more efficient fleet. It was a more trustworthy one — one that could demonstrate compliance, prove delivery accuracy, and scale without proportionally scaling overhead.

Dwell Time Reduction — The Hidden Efficiency Win

Dwell time — the time a vehicle spends stationary at a loading dock, transfer hub, or delivery point — is one of the least visible but most costly contributors to empty miles and fleet underutilization. Every minute a vehicle sits idle is a minute it isn’t generating productive miles.

Before intelligent routing, dwell time in multi-facility pharma networks is typically untracked. Vehicles arrive at hubs without pre-scheduled dock appointments. Transfers wait for manual handoff confirmation. Drivers idle while paperwork catches up to the physical product.

nuVizz clients consistently report significant dwell time reductions after deployment, driven by:

• Inbound appointment scheduling — vehicles arrive at hubs with pre-confirmed dock slots, eliminating queuing and idle wait times
• Real-time transfer coordination — hub teams are notified of incoming loads in advance, enabling preparation that eliminates handling delays
• Digital handoff documentation — ePOD and chain-of-custody records are completed digitally at the point of transfer, removing the paper-based delays that previously extended every hub stop

The compound effect of reduced dwell time across a multi-facility network is significant: vehicles complete more stops per shift, return to base earlier, and are available for the next dispatch cycle sooner — directly reducing the need for additional fleet capacity.

The Cost Impact — What Empty Mile Reduction Actually Saves

The financial case for intelligent routing in pharma distribution is straightforward — once the full cost of empty miles is properly accounted for. Most distributors track fuel cost and driver hours. Fewer track the full loaded cost of an empty mile: fuel, driver time, vehicle depreciation, maintenance allocation, and the opportunity cost of capacity that could have carried revenue-generating product.

When nuVizz clients reduce empty miles by 20% to 30% across their fleet, the savings compound across every one of those cost components simultaneously. For a mid-sized pharma distributor running 40 vehicles across five facilities, a 25% reduction in empty miles translates to:

• Tens of thousands of gallons of fuel saved annually
• Hundreds of driver hours recovered — reallocated to productive delivery capacity
• Measurable reduction in vehicle wear — extending fleet asset life and reducing maintenance spend
• Lower carrier spend — as consolidated loads and backhaul optimization reduce the total number of carrier trips required

And critically — these savings don’t require adding headcount. They’re generated by deploying smarter technology across an existing network.

Delivery Accuracy — Where Pharma Can’t Afford Anything Less Than 100%

In retail logistics, a 97% or 98% on-time, accurate delivery rate is considered excellent performance. In pharmaceutical distribution, it isn’t good enough — because the 2% or 3% that didn’t arrive correctly isn’t a dissatisfied customer. It’s a missed medication. A delayed treatment. A patient who didn’t receive what they needed, when they needed it.

nuVizz’s platform is built around the operational goal of 100% delivery accuracy — and the data across its pharma client base reflects consistent progress toward that benchmark:

• AI-powered dynamic routing eliminates the human planning errors that cause misrouted shipments
• Real-time exception management catches delivery issues before they become missed deliveries
• ePOD capture with photo and signature verification creates an irrefutable record of every successful delivery
• Proactive customer notifications keep recipients informed and prepared — reducing failed delivery attempts caused by unavailable recipients or unprepared receiving teams

The outcome is a delivery operation that doesn’t just move product efficiently — it moves it accurately, verifiably, and with the complete documentation trail that pharma distribution demands.

Operational Transformation — From Firefighting to Forward Planning

Perhaps the most significant — and least easily quantified — outcome nuVizz clients describe is the shift in how their operations teams spend their time.

Before nuVizz: Dispatchers spend their days reacting. Chasing carrier updates. Reconstructing delivery records. Managing exceptions manually. Fielding “where is my order?” calls from hospitals and pharmacies. Rebuilding routes when drivers call in late or traffic disrupts a plan.

After nuVizz: The system handles the reactive work. Exceptions are flagged automatically. Routes are reoptimized without dispatcher intervention. Customers receive proactive delivery notifications before they think to call. And operations teams — freed from constant firefighting — shift their focus to forward planning, network optimization, and strategic carrier management.

“Before nuVizz, my workdays were full of surprises. Missed delivery windows and mysterious delays left facilities scrambling, and I was constantly reacting instead of planning. Gaining real-time visibility and digital proof of delivery changed everything. Now, I can see every shipment on a single dashboard, track ETAs accurately, and actually plan ahead.” — Operations Manager, nuVizz Healthcare Client

This operational shift is what sustainable pharma distribution efficiency looks like. Not just better numbers on a KPI dashboard — but a fundamentally different way of running a network. One where the technology does the reactive work, and the people do the strategic work.

The results nuVizz delivers across pharma and healthcare distribution clients point to a consistent conclusion: the gap between a manually managed multi-facility pharma network and an intelligently optimized one is not marginal — it’s transformational.

Empty miles drop. Delivery accuracy rises. Compliance posture strengthens. Costs fall. And the operations teams managing it all shift from reactive to strategic — running a smarter network with the same or fewer resources.

Optimized pharma routing doesn’t just look different on a dashboard. It feels different across the entire organization — from the dispatch console to the compliance office to the patient waiting on a critical medication.

Retail brands winning customer loyalty are investing in faster, smarter, and more reliable delivery operations. See What’s Changing

How to Get Started — Evaluating an Intelligent Routing Solution

If the challenges covered in this guide sound familiar — empty miles climbing, dispatch teams firefighting, compliance documentation lagging, 3PL visibility breaking down across facilities — then the next step isn’t more analysis. It’s evaluation.

But not every Last Mile TMS is built for the complexity of pharmaceutical distribution. A platform that works well for retail or e-commerce logistics may lack the cold chain awareness, compliance depth, or multi-facility coordination capabilities that pharma networks specifically require. Choosing the wrong platform doesn’t just fail to solve the problem — it adds a new layer of complexity on top of an already complex operation.

Here’s exactly what to look for — and the questions to ask — when evaluating an intelligent routing solution for multi-facility pharma distribution.

The Pharma Routing TMS Evaluation Checklist

Use this checklist as your evaluation framework. A platform purpose-built for pharmaceutical distribution should meet every criterion below — not most of them.

1. Multi-Facility Support — Can It Coordinate Across Your Entire Network?

This is the foundational capability. A pharma TMS that optimizes routing within a single facility but can’t coordinate across multiple DCs, hubs, and transfer points is solving the wrong problem.

What to look for:

• Single unified dashboard covering all facilities simultaneously
• Cross-facility load consolidation and route planning
• Single-user dispatch capability across multiple distribution centers
• Network-wide visibility into every active vehicle, order, and exception
• Trunk and relay routing support for inter-facility product movement

Questions to ask the vendor:

• Can one dispatcher manage and dispatch from five or more facilities simultaneously?
• How does the platform handle load consolidation across facilities with different order volumes?
• What happens to visibility when product moves between facilities and changes carrier?

2. AI/ML Route Engine — Is the Optimization Truly Intelligent?

Not all “AI-powered” routing claims are equal. Some platforms apply basic optimization algorithms to fixed route templates. A genuinely intelligent route engine continuously learns, adapts, and reoptimizes — in real time, across the full complexity of a pharma distribution network.

What to look for:

• Dynamic route reoptimization throughout the execution day — not just at planning stage
• Real-time traffic, weather, and road condition integration
• Constraint-aware routing — load weight, temperature zones, delivery windows, HOS limits
• Predictive demand forecasting for proactive capacity alignment
• ML-driven continuous improvement — the system gets smarter with every delivery cycle

Questions to ask the vendor:

• How does the routing engine respond to a mid-route disruption — traffic, driver issue, urgent STAT order?
• What data inputs does the AI engine use, and how frequently is it updated?
• Can the system demonstrate measurable route efficiency improvement over time?

3. Cold Chain Integration — Is Temperature Compliance Built In or Bolted On?

Cold chain compliance cannot be an afterthought in a pharma routing platform. If temperature monitoring is a third-party add-on that requires manual reconciliation with routing data, it’s not a solution — it’s another system to manage.

What to look for:

• Native IoT temperature sensor integration — real-time monitoring throughout transit
• Automated exception alerts when temperature thresholds are breached
• Temperature zone enforcement at the route planning stage — not just monitoring in transit
• Continuous temperature logging linked directly to delivery and ePOD records
• Cold chain event documentation that is automatically audit-ready

Questions to ask the vendor:

• How does the platform handle a temperature excursion mid-delivery — what’s the alert workflow?
• Is temperature data captured and stored against individual shipment records automatically?
• Can the system enforce cold chain vehicle qualification rules at the dispatch stage?

4. Compliance Capabilities — Is Regulatory Support Embedded or Manual?

A platform that requires your compliance team to manually extract and reconstruct documentation from routing data is not a compliant platform — it’s a routing tool with a compliance workaround. Regulatory support must be embedded in every workflow, not applied after the fact.

What to look for:

• Native DSCSA serialization and chain-of-custody tracking
• GDP-compliant transfer documentation generated automatically at every hub handoff
• HIPAA-compliant data handling for patient-specific delivery information
• Electronic Proof of Delivery (ePOD) with signature, photo, and timestamp capture
• Instant, audit-ready retrieval of all compliance documentation
• SOC2 Type II, ISO 27001, AES 256, and HIPAA certification at platform level

Questions to ask the vendor:

• How does the platform maintain DSCSA compliance when a carrier substitution occurs mid-route?
• Where is compliance documentation stored, and how quickly can it be retrieved for an audit?
• What certifications does the platform hold — and when were they last renewed?

5. 3PL & Carrier Orchestration — Can It Manage Your Entire Carrier Ecosystem?

Most pharma distributors don’t operate with a single carrier. They manage a mixed ecosystem of owned fleet, contracted carriers, and 3PL partners — each with its own operational habits. A TMS that only manages owned fleet leaves the majority of your network uncoordinated and invisible.

What to look for:

• Unified onboarding for owned fleet, contracted carriers, and 3PL partners
• Carrier app or API integration that extends platform visibility to every driver — regardless of employer
• Standardized SOPs enforced across all carrier types through the platform
• Consistent KPI tracking and performance reporting across owned and outsourced fleet
• Automated billing and settlement based on verified ePOD data — across all carrier types
• Exception management workflow that covers every carrier in the network equally

Questions to ask the vendor:

• How are 3PL carriers onboarded — app, API, or both?
• Can the platform enforce documentation and compliance standards on third-party drivers?
• How does carrier performance data flow back into route planning and carrier selection decisions?

Beyond the Checklist — Three Final Evaluation Tests

Once a platform clears the checklist above, apply these three final tests before making a decision:

Test 1: The Disruption Test Ask the vendor to demonstrate, live, how the platform responds to a mid-route disruption — a driver going unavailable, an urgent STAT order added, a traffic incident blocking the primary route. A genuinely intelligent platform should reoptimize automatically and visibly, in real time. If the demo requires manual intervention to resolve the disruption, that’s your answer.

Test 2: The Audit Test Ask the vendor to pull a complete compliance documentation package for a specific hypothetical shipment — chain of custody, temperature log, ePOD, DSCSA transaction record. Ask how long it takes. If the answer involves exporting data from multiple systems and compiling it manually, the platform wasn’t built for pharma compliance. If it’s a single report pull — it was.

Test 3: The Scale Test Ask the vendor to demonstrate the platform managing five or more facilities simultaneously — with live orders, active vehicles, and cross-facility routing decisions happening in a single view. Multi-facility coordination at scale is where most general-purpose TMS platforms break down. It’s where a purpose-built pharma platform like nuVizz is specifically designed to perform.

Why nuVizz Meets Every Criterion

nuVizz was purpose-built for the operational and regulatory complexity of pharmaceutical and healthcare distribution. Every capability on this checklist — multi-facility dispatch, AI/ML route optimization, cold chain integration, DSCSA and GDP compliance, and full carrier orchestration — is a core, native feature of the nuVizz platform. Not a module to purchase separately. Not a third-party integration to manage independently. Built in, from the ground up, for pharma.

Evaluation Criterion	nuVizz Capability
Multi-Facility Support	✅ Single-user dispatch across unlimited DCs
AI/ML Route Engine	✅ Dynamic reoptimization, predictive demand matching
Cold Chain Integration	✅ Native IoT sensor integration, real-time alerts
Compliance Capabilities	✅ DSCSA, GDP, HIPAA, SOC2, ISO 27001, AES 256
3PL/Carrier Orchestration	✅ Unified ecosystem management, standardized SOPs

Choosing a Last Mile TMS for pharma distribution isn’t just a technology decision — it’s a compliance decision, a patient safety decision, and a strategic network decision. Make it with a platform built specifically for the stakes involved.

Conclusion — Every Empty Mile Is a Choice

Empty miles in pharmaceutical distribution are not inevitable. They are not an unavoidable cost of running a complex multi-facility network. They are the predictable outcome of routing systems, dispatch processes, and visibility tools that weren’t built for the scale and complexity of modern pharma logistics.

Every empty mile your fleet drives is a decision that could have been made differently — with better data, smarter routing, and a platform that sees your entire network as one coordinated system rather than a collection of disconnected facilities.

The good news? That platform exists.

nuVizz was purpose-built for exactly this challenge — multi-facility pharma distribution, where efficiency and compliance aren’t competing priorities but simultaneous operating requirements. From AI-powered dynamic routing and cross-facility load consolidation to cold chain monitoring, DSCSA compliance, and full carrier orchestration, nuVizz gives pharma distributors the intelligence, visibility, and control to eliminate empty miles — not just reduce them.

The distributors who act on this now won’t just lower their cost per delivery. They’ll build a more resilient network, a stronger compliance posture, and a more reliable supply chain for the patients depending on every shipment they send.

Ready to Eliminate Empty Miles Across Your Pharma Network?

The first step is seeing exactly where your inefficiency lives — and what’s possible when intelligent routing works across every facility, every fleet, and every carrier in your network simultaneously.

See how nuVizz reduces empty miles across your pharma network — Request a Demo Today